Particle size variability impacts performance during deviation investigation – preventing batch rejection and recall


Published on 24/04/2026

Understanding How Particle Size Variability Affects Performance in Deviation Investigations

Particle size variability in active pharmaceutical ingredients (APIs) can present significant challenges in pharmaceutical manufacturing, often leading to batch rejection and recalls. This article will guide you through a structured investigation into such variability, empowering you with practical strategies for effective root cause analysis, corrective actions, and preventive steps to mitigate future risks.

By the end of this article, you will understand how to detect symptoms related to particle size variability, categorize likely causes, and implement a robust investigation workflow that aligns with industry standards.

Symptoms/Signals on the Floor or in the Lab

Identifying signals that reflect particle size variability is crucial for timely intervention. Symptoms can manifest as batch performance issues or quality complaints from the lab or production floor. Common indicators include:

  • Variability in Dissolution Rates: Inconsistent dissolution profiles can signal particle size inconsistency.
  • Increased Product Rejections: Higher than acceptable failure rates during in-process testing or final quality control checks.
  • Quality Complaints: Reports
from customers related to performance anomalies that correlate with particle size differences.
  • Unusual Equipment Behavior: Increased wear on processing equipment or changes in flow characteristics during blending.
  • Establishing baseline metrics during development stages can help in quick recognition of these symptoms, aiding in rapid response protocols.

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    When investigating deviations related to particle size variability, categorizing the causes helps in systematic identification and mitigation:

    Category Potential Cause
    Materials Inconsistent quality of the raw materials or variances in supplier particle size distribution.
    Method Inadequate blending or milling processes that fail to produce uniform particle size.
    Machine Equipment failures or suboptimal settings that do not achieve desired particle size limits.
    Man Operator error in measurement or application of the manufacturing process.
    Measurement Inaccurate measurement techniques or calibration issues with analytical instruments.
    Environment Inconsistent environmental conditions such as humidity and temperature affecting powder characteristics.

    Investigating each of these areas enables a comprehensive view of potential causes, allowing for effective remediations.

    Immediate Containment Actions (first 60 minutes)

    Immediately upon detecting particle size variability, initiating containment actions is critical:

    • Cease Production: Halt processing of the affected batch to prevent further complications.
    • Quarantine Affected Batches: Isolate materials suspected to contribute to the variability to prevent cross-contamination.
    • Notify Relevant Departments: Alert quality control, quality assurance, and production teams to facilitate quick data gathering and corrective measures.
    • Initiate Investigation Protocol: Begin collecting relevant data on equipment performance, raw materials, and process deviations.

    These actions minimize the impact of the deviation and establish a clear path for subsequent investigations.

    Investigation Workflow (data to collect + how to interpret)

    Your investigation workflow should include systematic steps to collect and analyze data relevant to particle size variability:

    1. Data Gathering: Collect all relevant records from the manufacturing and quality control teams including material specifications, production logs, and analytical testing results.
    2. Analyze Variability: Employ statistical tools to assess the extent and impact of size variability on batch performance, utilizing techniques such as Statistical Process Control (SPC).
    3. Sample Testing: If possible, analyze size distributions from batches to identify discrepancies, utilizing laser diffraction or sieve analysis.
    4. Traceability Check: Verify the traceability of raw materials, equipment used, and conditions maintained during processing.

    Ensure thorough documentation throughout this workflow for transparency and regulatory compliance.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Utilizing structured root cause analysis tools is essential for identifying and addressing particle size variability:

    • 5-Why Analysis: An effective method to drill down from a symptom to its root cause by iteratively asking “why.” Ideal for simple issues or those that seem minor.
    • Fishbone Diagram (Ishikawa): Great for visualizing various potential causes categorized by the 5Ms: Man, Machine, Method, Material, and Measurement. Suitable for complex issues with multiple factors.
    • Fault Tree Analysis: A systematic, deductive approach that starts with the problem and maps out all possible causes in a tree format. Best for high-stakes failures where meticulous tracking of multiple variables is critical.

    Select the tool that best aligns with the size and complexity of the problem being investigated.

    CAPA Strategy (correction, corrective action, preventive action)

    To address the findings of the investigation, a comprehensive Corrective and Preventive Action (CAPA) plan must be developed:

    • Correction: Immediate actions taken to remedy the symptoms. This can include the recall of affected batches and adjustments in processing conditions.
    • Corrective Action: Longer-term measures targeted at addressing root causes. This could involve material supplier re-evaluation, adjustments to processing methods, or equipment upgrades.
    • Preventive Action: Steps to ensure similar issues do not occur in the future, such as revised training programs for staff and improved monitoring systems.

    A robust CAPA strategy strengthens overall process integrity and aligns with regulatory expectations for ongoing improvement.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    Establishing a control strategy is integral to ongoing quality assurance:

    • Statistical Process Control (SPC): Implement SPC charts to monitor particle size distribution over time, enabling early detection of deviations.
    • Regular Sampling: Design a sampling plan for incoming materials and in-process checks, helping to ensure consistent quality.
    • Alarms and Alerts: Set up automated alerts for any deviations in predetermined quality parameters, allowing for rapid response to emerging issues.
    • Ongoing Verification: Schedule routine audits to evaluate the effectiveness of controls and compliance with revised procedures.

    A well-structured control strategy not only mitigates risks but also helps in maintaining inspection readiness.

    Related Reads

    Validation / Re-qualification / Change Control Impact (when needed)

    Should significant changes be made to processes or materials as a result of your investigation, a validation strategy must be established:

    • Validation of Changes: Any significant modification to raw materials, processes, or analytical methods necessitates validation, ensuring consistency and compliance.
    • Re-qualification: Equipment may require re-qualification to ensure it operates within defined acceptable ranges post-intervention.
    • Change Control Documentation: All changes, whether minor or significant, should go through a change control process to maintain traceability and compliance.

    Understanding the potential impact of changes is vital for ensuring continued compliance with USP, EP, and IP guidelines.

    Inspection Readiness: What Evidence to Show (records, logs, batch docs, deviations)

    During regulatory inspections, it’s essential to present clear, comprehensive evidence as to how particle size variability issues were handled:

    • Records: Maintain accurate, retrievable records of all investigations, findings, and CAPA actions taken, in line with FDA and EMA expectations.
    • Logs: Ensure production and quality control logs reflect any incidents related to particle size variability, showcasing transparency in operations.
    • Batch Documentation: Ensure batch records include pertinent testing parameters and results that illustrate compliance with specifications.
    • Deviation Reports: Document deviations comprehensively, including root cause evaluations and actions taken.

    Such documentation not only demonstrates compliance but also establishes a culture of quality throughout the organization.

    FAQs

    What are the most common symptoms of particle size variability?

    Common symptoms include variability in dissolution rates, increased product rejections, and quality complaints.

    How can we quickly contain a particle size variability issue?

    Cease production, quarantine affected batches, and notify relevant departments immediately.

    What tools are best for root cause analysis?

    5-Why analysis is effective for simple issues, while Fishbone diagrams and Fault Tree analysis are useful for more complex scenarios.

    What is a CAPA strategy?

    A CAPA strategy includes corrective actions to remedy existing symptoms, and preventive actions to address root causes and future risks.

    How do we ensure inspection readiness for particle size issues?

    Maintain accurate records, logs, and documentation of all investigations and quality control measures related to particle size.

    What is the role of SPC in managing particle size variability?

    SPC helps monitor particle size distribution over time, allowing early detection and intervention for variances.

    When should we conduct validation or re-qualification?

    Validation or re-qualification is necessary whenever significant changes to processes, materials, or equipment occur.

    How do we develop a control strategy for raw materials?

    Implement consistent sampling plans, SPC monitoring, and regular audits to ensure compliance with quality standards.

    Why is traceability important in particle size investigations?

    Traceability enables an understanding of material flow and helps identify the source of variability effectively.

    How can we improve training related to particle size and quality management?

    Regularly update training programs to focus on the impacts of particle size variability and effective quality assurance techniques.

    What documentation is needed for successful investigation outcomes?

    Documentation should include records of investigations, CAPA actions, and relevant quality control data for regulatory compliance and transparency.

    How can suppliers contribute to managing particle size variability?

    Suppliers can provide consistent quality assurance practices and materials quality specifications that meet regulatory standards.

    Pharma Tip:  API stability failure during regulatory inspection – regulatory impact assessment